News and Resources

News and resources

Spain: two decades of leadership in innovative global health financing

25 Mar 2026

For nearly 20 years, Spain has been a steadfast and increasingly ambitious partner in global immunisation, distinguished by its early and sustained embrace of innovative financing tools.

Italy: A founding partner and longstanding leader in vaccine financing

25 Mar 2026

For nearly two decades, Italy has been a leading supporter of global immunisation through IFFIm, of which it is a founding member.

Charting the next chapter: IFFIm launches strategic review ahead of its 20th anniversary

25 Mar 2026

The review focuses on IFFIm’s continuing role as financing partner for global immunisation in the years ahead.

IFFIm receives A+ rating from the UK’s FCDO for the seventh consecutive year

25 Mar 2026

Latest UK Foreign, Commonwealth & Development Office (FCDO) rating reaffirms IFFIm’s position in global health finance.

Twenty years of IFFIm: the power of finance to save lives

20 Mar 2026

In a packed parliamentary chamber in Brasília, Gavi’s departing Chief Resource Mobilisation & Growth Officer Marie-Ange Saraka-Yao watched lawmakers debate whether Brazil should commit to a global financing instrument most had never heard of. The questions were pointed. The scepticism was real. Why commit public funds so far into the future?

IFFIm financing drives historic breakthrough in malaria vaccine affordability

20 Mar 2026

A novel IFFIm transaction enables Gavi and UNICEF to secure an equitable pricing agreement that will make malaria vaccines more affordable and expand access to millions of children, redefining what innovative finance can achieve.

Q&A with new IFFIm Board Chair Georgina Baker

20 Mar 2026

Ms Baker joined the IFFIm board on 1 January 2026 as its new Chair as outgoing Chair Ken Lay remains on the board as a Director through 2026. We asked her about her experiences and her perspective on her new role.